delete The National Health Service (Local Pharmaceutical Services and Pharmaceutical Services) Regulations 2002
These Regulations implement Section 30 of the Health and Social Care Act 2001, establishing a framework for Health Authorities to designate neighborhoods, premises, or descriptions of premises for local pharmaceutical services pilot schemes. They set out procedures for making, varying, reviewing, and cancelling designations; rules for financial assistance for preparatory work; and amend the 1992 Pharmaceutical Services Regulations to add deferral powers (Regulation 6A) allowing Health Authorities to defer consideration of pharmacy applications relating to designated areas.
These regulations create a bureaucratic designation system that restricts where pharmaceutical services may be provided, effectively suppressing competition through central planning rather than market mechanisms. The deferral power in Regulation 6A allows Health Authorities to delay or block pharmacy applications in designated areas, reducing supply and entrenching existing providers. As with all location-based regulatory controls, this will distort incentives, reduce competition, and harm consumers through fewer choices and higher prices. The NHS's near-monopoly position on healthcare is reinforced by such restrictions on pharmacy supply. A free market in pharmaceutical services would allow providers to respond to demand signals without bureaucratic gatekeeping.